Clinical Trial Update: R-ONE® Robotically-Enhanced PCI Intervention Study [NA]

View source ↗

Summary

The R-ONE robotically enhanced PCI intervention study sponsored by Cathbot (Shanghai) Robot Co., Ltd. has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases

Snippet

Sponsor: Cathbot (Shanghai) Robot Co., Ltd | Conditions: Cardiovascular Diseases | NA | Status: COMPLETED